VanEck Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164M Sell
644,520
-92,308
-13% -$21.5M 0.1% 138
2026
Q1
$180M Sell
736,828
-16,954
-2% -$3.95M 0.14% 136
2025
Q4
$156M Buy
753,782
+138,900
+23% +$27.5M 0.13% 142
2025
Q3
$114M Sell
614,882
-246,677
-29% -$42.3M 0.11% 146
2025
Q2
$132M Buy
861,559
+95,947
+13% +$14.7M 0.15% 128
2025
Q1
$127M Sell
765,612
-32,802
-4% -$5.13M 0.16% 122
2024
Q4
$115M Buy
798,414
+18,228
+2% +$2.82M 0.15% 123
2024
Q3
$129M Buy
780,186
+88,107
+13% +$14M 0.16% 109
2024
Q2
$101M Buy
692,079
+27,692
+4% +$4.12M 0.14% 117
2024
Q1
$105M Buy
664,387
+74,871
+13% +$11.9M 0.16% 116
2023
Q4
$92.4M Buy
589,516
+35,921
+6% +$5.51M 0.17% 120
2023
Q3
$86.2M Buy
553,595
+29,871
+6% +$4.93M 0.19% 118
2023
Q2
$86.7M Sell
523,724
-47,963
-8% -$7.74M 0.19% 117
2023
Q1
$88.6M Sell
571,687
-69,873
-11% -$11.3M 0.2% 115
2022
Q4
$113M Sell
641,560
-67,347
-10% -$11.6M 0.29% 90
2022
Q3
$116M Buy
708,907
+130,549
+23% +$22.1M 0.34% 79
2022
Q2
$103M Buy
578,358
+77,489
+15% +$13.8M 0.27% 95
2022
Q1
$88.8M Buy
500,869
+28,786
+6% +$4.9M 0.18% 131
2021
Q4
$80.8M Buy
472,083
+55,243
+13% +$9.04M 0.19% 126
2021
Q3
$67.3M Buy
416,840
+62,405
+18% +$10.6M 0.17% 142
2021
Q2
$58.4M Buy
354,435
+16,302
+5% +$2.7M 0.14% 158
2021
Q1
$55.6M Buy
338,133
+45,879
+16% +$7.42M 0.15% 144
2020
Q4
$46M Buy
292,254
+26,163
+10% +$3.86M 0.13% 138
2020
Q3
$39.6M Buy
266,091
+31,166
+13% +$4.61M 0.13% 130
2020
Q2
$33M Buy
234,925
+36,084
+18% +$5.26M 0.12% 139
2020
Q1
$26.1M Buy
198,841
+4,593
+2% +$652K 0.13% 128
2019
Q4
$28.3M Buy
194,248
+132,573
+215% +$18M 0.11% 147
2019
Q3
$7.98M Buy
61,675
+1,035
+2% +$136K 0.04% 252
2019
Q2
$8.45M Sell
60,640
-6,304
-9% -$873K 0.04% 248
2019
Q1
$9.36M Sell
66,944
-55,457
-45% -$7.43M 0.05% 224
2018
Q4
$15.8M Sell
122,401
-7,759
-6% -$1.08M 0.08% 188
2018
Q3
$18M Sell
130,160
-14,413
-10% -$1.92M 0.09% 191
2018
Q2
$17.5M Buy
144,573
+47,551
+49% +$5.93M 0.08% 190
2018
Q1
$12.4M Buy
97,022
+1,681
+2% +$227K 0.06% 219
2017
Q4
$13.3M Sell
95,341
-9,803
-9% -$1.37M 0.07% 213
2017
Q3
$13.7M Sell
105,144
-75,195
-42% -$9.97M 0.07% 219
2017
Q2
$23.9M Sell
180,339
-97,252
-35% -$12.4M 0.13% 137
2017
Q1
$34.6M Sell
277,591
-1,687
-0.6% -$202K 0.15% 112
2016
Q4
$32.2M Buy
279,278
+143,016
+105% +$16.5M 0.16% 104
2016
Q3
$16.1M Sell
136,262
-4,340
-3% -$527K 0.07% 166
2016
Q2
$17.1M Sell
140,602
-1,043
-0.7% -$119K 0.09% 143
2016
Q1
$15.3M Sell
141,645
-144,900
-51% -$15M 0.1% 135
2015
Q4
$29.4M Buy
286,545
+24,849
+9% +$2.5M 0.23% 106
2015
Q3
$24.4M Sell
261,696
-12,720
-5% -$1.23M 0.19% 120
2015
Q2
$26.7M Sell
274,416
-21,610
-7% -$2.16M 0.16% 127
2015
Q1
$29.8M Buy
296,026
+5,948
+2% +$605K 0.17% 122
2014
Q4
$30.3M Sell
290,078
-130,125
-31% -$13.7M 0.19% 112
2014
Q3
$44.8M Buy
420,203
+62,434
+17% +$6.48M 0.24% 99
2014
Q2
$37.4M Buy
357,769
+55,587
+18% +$5.62M 0.17% 116
2014
Q1
$29.7M Buy
302,182
+38,995
+15% +$3.62M 0.15% 120
2013
Q4
$24.1M Buy
263,187
+6,147
+2% +$567K 0.12% 126
2013
Q3
$22.3M Sell
257,040
-47,766
-16% -$4.29M 0.11% 105
2013
Q2
$26.2M Buy
+304,806
New +$25.9M 0.14% 98

Other funds holding JNJ

VanEck Associates's JNJ Position: Q2 2026 in Review

VanEck Associates reduced its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, selling an estimated $21.5M and leaving 644,520 shares worth $164M. The position accounts for 0.1% of the portfolio, ranked #138.

VanEck Associates first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $180M in Q1 2026. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • VanEck Associates held 644,520 shares of Johnson & Johnson worth $164M as of Q2 2026.
  • VanEck Associates sold 92,308 Johnson & Johnson shares in Q2 2026, an estimated $21.5M.
  • Johnson & Johnson made up 0.1% of VanEck Associates's portfolio in Q2 2026, its #138 holding.
  • VanEck Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • VanEck Associates's Johnson & Johnson position peaked at $180M in Q1 2026.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.